The herbicidal compositions, methods for protecting crops from the herbicidal activity of the inhibitor of photosystem I and method for increasing the selectivity of herbicidal compositions

摘要

1. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0, u0441u043eu0434u0435u0440u0436u0430u0449u0430u00a0 inhibitor u0444u043eu0442u043eu0441u0438u0441u0442u0435u043cu044b i and salicylate or another inducer of systemic acquired resistance.;2. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inhibitor u0444u043eu0442u043eu0441u0438u0441u0442u0435u043cu044b i u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a paraquat or u0434u0438u043au0432u0430u0442.;3. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inhibitor u0444u043eu0442u043eu0441u0438u0441u0442u0435u043cu044b i u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 from 99.999 to 0.001% of the composition, and salicylate or another inducer acquired sustainable system u0447u0438u0432u043eu0441u0442u0438 u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 from 99.999 to 0.001% of the composition.;4. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, u043au043eu0442u043eu0440u0430u00a0 u0440u0430u0441u0442u0432u043eu0440u0435u043du0430 in water.;5. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on paragraph 4, in which the water u0441u043eu0441u0442u0430u0432u043bu00a0u0435u0442 from 0.1 up to 99.99% of the composition.;6. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a s - methyl ether benzo (1, 2, 3) u0442u0438u0430u0434u0438u0430u0437u043eu043b - 7 - u043au0430u0440u0431u043eu0442u0438u043eu043bu043eu0432u043eu0439 kee slots (u0432u0442u043d) or biologically acceptable derivative or their salt.;7. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a protein Harpin or biologically acceptable salt.;8. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a Keyplex 350 - dp or other drug Keyplex.;9. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 a 2 - butyl - 1.2 - u0431u0435u043du0437u043eu0438u0437u043eu0442u0438u0430u0437u043eu043b - 3 (2h) - 1,1 dioxide (Probenazole) or his the biologically acceptable derivative or their salt.;10. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 an activator u0432u043au043bu044eu0447u0430u00a0 fragments from the cell walls of fungal infections. or a composition based on activation.;11. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which the inducer of systemic acquired resistance u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 an ethylene or any composition, which u0432u044bu0434u0435u043bu00a0u0435u0442 ethylene in st. oem destruction.;12. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which a u0441u0430u043bu0438u0446u0438u043bu043eu0432u0443u044e salicylate u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 acid or its biologically acceptable salt.;13. u0433u0435u0440u0431u0438u0446u0438u0434u043du0430u00a0 u043au043eu043cu043fu043eu0437u0438u0446u0438u00a0 on 1, in which a u043du0430u0442u0440u0438u00a0 salicylate u043fu0440u0435u0434u0441u0442u0430u0432u043bu00a0u0435u0442 salicylate.;14. method of protecting crops from u0441u0435u043bu044cu0441u043au043eu0445u043eu0437u00a0u0439u0441u0442u0432u0435u043du043du044bu0445 u0433u0435u0440u0431u0438u0446u0438u0434u043du043eu0439 activity inhibitor u0444u043eu0442u043eu0441u0438u0441u0442u0435u043cu044b i, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 because u0438u043du0433u0438u0431u0438u0442u043eu0440u0443 u0434u043eu0431u0430u0432u043bu00a0u044eu0442 effective u043au043eu043bu0438u0447u0435u0441 young man. u0438u043du0434u0443u043au0442u043eu0440u0430 systemic acquired resistance.;15. method u0443u0432u0435u043bu0438u0447u0435u043du0438u00a0 selectivity u0433u0435u0440u0431u0438u0446u0438u0434u043du043eu0439 composition containing the inhibitor u0444u043eu0442u043eu0441u0438u0441u0442u0435u043cu044b i, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 because u0434u043eu0431u0430u0432u043bu00a0u044eu0442 effective amount of composition u0438u043du0434u0443u043au0442u043eu0440u0430 systemic acquired resistance.